NCT06391294

Brief Summary

Electrocortical stimulation (ECS) mapping is a procedure used during brain surgeries, for example when treating diseases like epilepsy or when removing brain tumors. ECS mapping helps surgeons locate areas of the cerebral cortex (the outer part of the brain) that are important for everyday tasks like movement and speech. ECS mapping has been used for decades, and is considered the "gold-standard" tool for locating important areas of cortex. Despite this long history, there is still no clear understanding of exactly how ECS works. The goal of this study is to learn details about the effects ECS has on the brain. The main questions the study aims to answer are: 1) how ECS affects the neurons of the cortex at the stimulation site; and 2) how ECS impacts brain regions that are critically important for human speech and language. These so-called "critical sites" can be physically distant from one another on the brain's surface, requiring extensive ECS mapping and long surgeries. Critical sites are thought to be part of a speech/language network of brain areas, and so the study's goal is to learn about how they are connected. In some participants, the brain's surface will also be slightly cooled. This is a painless procedure that does not harm the brain's function, but could provide insight as to which parts of the brain (the surface, or deeper parts) are responsible for the effects of ECS. By improving the understanding of how ECS affects the brain and improving the ability to identify critical sites, this study could potentially lead to shorter surgeries and better outcomes for future individuals who need this care. Participants will be recruited from among individuals who are undergoing brain surgery for epilepsy treatment or tumor removal. Participants will complete simple tasks like reading words or naming pictures, similar to standard testing that is already performed during their hospital stay.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
51mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
May 2024Jun 2030

First Submitted

Initial submission to the registry

April 5, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 30, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

May 17, 2024

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2030

Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

5.1 years

First QC Date

April 5, 2024

Last Update Submit

September 2, 2025

Conditions

Keywords

Electrocortical StimulationElectrocorticography

Outcome Measures

Primary Outcomes (1)

  • Critical node decoding performance

    Accuracy at decoding critical nodes from network connectivity metrics using machine learning algorithms.

    Up to 1 week during ECoG recording

Secondary Outcomes (1)

  • Language function

    Up to 4 hours during ECoG recording

Study Arms (1)

Experimental group

EXPERIMENTAL

Single arm of the study

Procedure: Focal cortical cooling

Interventions

Focal cortical cooling will be applied

Experimental group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Requiring awake, cortical mapping for brain tumor resection or implantation of intracranial electrodes for extraoperative monitoring for epilepsy
  • For extraoperative patients: Planned electrode coverage including at least parts of frontal and temporal or parietal lobes, preferably both anterior (inferior frontal gyrus) and posterior language areas (superior temporal gyrus) in the language dominant hemisphere
  • For intraoperative patients: Planned craniotomy including parts of both frontal and temporal anterior and posterior language areas in the language dominant hemisphere.

You may not qualify if:

  • Significant language or speech impairment, including but not limited to aphasia, dysarthria, and apraxia of speech, consistently preventing patient from speaking words
  • Non English-speaking (because this is a study of language networks, and second language could be encoded differently)
  • Impaired cognitive function, as determined by neurological testing, such that the patient cannot follow test instructions or provide written informed consent
  • Tumor infiltrating, or within 1 cm of, multiple of the cortical or subcortical areas studied in this proposal (inferior frontal gyrus, precentral gyrus, superior temporal gyrus)
  • Ferromagnetic implants that are MRI incompatible or other contraindications to MRI
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Northwestern University

Chicago, Illinois, 60611, United States

Location

University of Iowa

Iowa City, Iowa, 52242, United States

Location

Johns Hopkins University

Baltimore, Maryland, 21218, United States

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Marc Slutzky

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 5, 2024

First Posted

April 30, 2024

Study Start

May 17, 2024

Primary Completion (Estimated)

June 30, 2029

Study Completion (Estimated)

June 30, 2030

Last Updated

September 9, 2025

Record last verified: 2025-09

Locations